RMP Rounds | Randomized Phase III Study in Newly Diagnosed Glioblastoma

RMP Rounds for Thursday October 13, 2016
Speaker: Dr. Normand Laperriere
Radiation Oncologist, Radiation Medicine Program,
Princess Margaret Cancer Centre
Professor, Department of Radiation Oncology, University of Toronto
Description:
A randomized phase III study of temozolomide and short-course radiation version short-course radiation alone in the treatment of newly diagnosed glioblastoma multiforme in elderly patients.
Learning Objectives:
Appreciate examples of the diversity of clinical research undertaken in collaboration with international colleagues and the challenges and advantages which are involved.